Thank you for standing by, and welcome to the BBOT Clinical Data Update Call. Today's program is being recorded. [Operator Instructions] I'd now like to introduce your host for today's program, ...
The state’s Board of Bar Overseers voted to issue a public reprimand for misconduct to disgraced former U.S. Attorney Rachael Rollins, but three members of the board dissented, preferring to reject ...
SOUTH SAN FRANCISCO, Calif., Oct. 23, 2025 (GLOBE NEWSWIRE) -- BridgeBio Oncology Therapeutics, Inc. (“BBOT”) (Nasdaq: BBOT), a clinical-stage biopharmaceutical company focused on RAS-pathway ...
Two former Plymouth County prosecutors have their careers on the line after a Board of Bar Overseers hearing panel found “unacceptable” misconduct on their part in a case that put a Brockton High ...
Microsoft is betting big on AI. Starting with integrating Bing with ChatGPT, it has implemented AI capabilities in its products. Microsoft Designer is a new product from Microsoft with AI capabilities ...
Mutations in the gene encoding PI3Kα are associated with several types of cancer, but selectively targeting oncogenic signalling while leaving physiological PI3Kα activity intact has proved ...
Imagine this: you’re in the middle of an important project, juggling deadlines, and collaborating with a team scattered across time zones. Suddenly, your computer crashes, and hours of work vanish in ...
A new cancer drug candidate has demonstrated the ability to block tumor growth without triggering a common and debilitating side effect. The compound was developed by Lawrence Livermore National ...
- Data show that BBO-10203 covalently and specifically binds to the RAS-binding domain of PI3Kα, breaking its interaction with H-, N-, and KRAS and preventing them from activating PI3Kα - In ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results